(S)-propranolol; (-)-propranolol; UNII-74MLR03FLC; 74MLR03FLC; (S)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol; CHEMBL452861; (2S)-1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol; Propranolol, L-; Q63390536; Levopropranolol; s-propranolol; 1-propranolol; (-)-propanolol; propranolol (S-); EINECS 224-095-5; S-(-)-propanolol; s-(-)-propranolol; Tocris-0834; (-)-(S)-Propranolol; Prestwick0_001081; Prestwick1_001081; Prestwick2_001081; Prestwick3_001075; Prestwick3_001081; GTPL63; SCHEMBL3956; Lopac0_001023; BSPBio_001040; BSPBio_001090; BSPBio_001122; KBioGR_000380; KBioSS_000380; SPBio_003021; BPBio1_001200; BPBio1_001236; (S)-(-)-PROPRANOLOL; BCBcMAP01_000208; CTK4I5506; KBio2_000380; KBio2_002948; KBio2_005516; KBio3_000739; KBio3_000740; ZINC56556; DTXSID90873366; Bio2_000360; Bio2_000840; HMS1362D21; HMS1792D21; HMS1990D21; HMS2089B07; 2-Propanol, 1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy)-, (S)-; BDBM50246936; MFCD00066276; PDSP1_000768; PDSP2_000756; CCG-205103; SDCCGSBI-0050996.P004; IDI1_002115; NCGC00024813-01; NCGC00024813-02; NCGC00024813-03; NCGC00024813-04; NCGC00024813-05; NCGC00024813-06; NCGC00024813-07; NCGC00024813-08; NCGC00024813-16; NCGC00024813-17; SBI-0050996.P003; AB00514695; AB00514695-07; AB00514695_08; BRD-K13994703-001-02-0; BRD-K13994703-003-04-2; BRD-K13994703-003-10-9; UNII-9Y8NXQ24VQ component AQHHHDLHHXJYJD-AWEZNQCLSA-N; (2S)-1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol; 1-((1-methylethyl)amino) 3-(1-naphthalenyloxy) 2-propanol; 2-Propanol,1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy)-, (2S)-; [2-Hydroxy-3-(naphthalen-1-yloxy)-propyl]-isopropyl-ammonium((-)-propranolol)